ASND Latest Headlines

Buy Rating for Ascendis Pharma Driven by Promising TransCon CNP Developments and Strong Growth Prospects

at www.tipranks.com (Fri, 4-Apr 2:36 AM)

Ascendis submits NDA for TransCon CNP for achondroplasia

at seekingalpha.com (Mon, 31-Mar 5:51 PM)

Ascendis Pharma Submits FDA Application for Achondroplasia Treatment

at www.tipranks.com (Mon, 31-Mar 4:29 PM)